Medigene AG
MDG1
Rankning i aktier
#35298
Medigene AG is a German biotechnology company primarily focused on innovating T... Medigene AG is a German biotechnology company primarily focused on innovating T cell immunotherapies to treat various cancers. Their developmental pipeline includes personalized T cell therapies, particularly T cell receptor-modified T cells, which are progressing through clinical stages to tackle significant unmet medical requirements. Additionally, the firm researches dendritic cell vaccines and T cell-specific monoclonal antibodies. Outside of its oncology efforts, Medigene is actively engaged in developing and bringing to market RhuDex for uses within hepatology and gastroenterology. A key strategic alliance exists with 2seventy bio, Inc., centered on advancing T cell receptors. The company also maintains research collaborations with the Université de Montréal and Cytovant Sciences Co. Ltd., investigating new cancer antigens for immunotherapy applications. Medigene's global presence encompasses operations across Europe, the United States, Asia, and various other international territories. Founded in 1994, the company's headquarters are located in Munich, Germany.
Aktiekurs
$0.14942078
Senast synkroniserad: 2025-05-15
Marknadsvärde
$3.86M
Förändring (1 dag)
0.10%
Förändring (1 år)
47.84%
Land
DE
Handel Medigene AG (MDG1)
Kategori
Healthcare
Historik för aktiesplit för Medigene AG (MDG1)
Aktien Medigene AG (symbol: MDG1) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Oct 21, 2026.
En MDG1-aktie köpt före Oct 21, 2026 motsvarar nu 0 MDG1-aktier.
Den senaste spliten skedde den Oct 21, 2026.
En MDG1-aktie köpt före Oct 21, 2026 motsvarar nu 0 MDG1-aktier.
Lista över aktiesplitar
| År | Split | Multipel | Kumulativ multipel |
|---|---|---|---|
| Inte tillräckligt med data för de angivna datumen. | |||
Aktiesplitar för liknande företag eller konkurrenter
| Företag | Antal aktiesplitar | Kumulativ multipel | Land |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
NL
|
|
| 0 | - |
CH
|
